In this continuation of our myeloma series, we discuss all the key principles and data surrounding autologous stem cell transplant in myeloma. We provide a succinct summary of key trials in this space that will give you a deep understanding of the field. Content:- What are all these cooperative groups in the studies?- What are some of the important trials that show us the benefit of autologous stem cell transplant? - Should transplant be done early or should it be delayed? What does it matter? - We translate the data/guidelines into what this means for patients in real-life- How do we approach transplant in high risk patients in myeloma and what are the guidelines about tandem transplant? This episode has been sponsored by Primum. To sign up for a free account, check out: tfoc.primum.co.Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodesLove what you hear? Tell a friend and leave a review on our podcast streaming platforms!Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Google Podcast

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related